Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s409368 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Xu Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
- Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, USA.
- Department of Pharmaceutical Research Laboratory, Chong Kun Dang Research Institute, Chong Kun Dang Pharmaceutical Corporation, Yongin, Republic of Korea.
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Xu Jiang, Sungyeun Bae, Jaeseong Oh, Joo-Youn Cho, Kyung-Sang Yu
Zitieren
APA
Jiang, X., Bae, S., Yoon, D. Y., Park, S. J., Oh, J., Cho, J. Y., & Yu, K. S. (2023). Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s409368
Vancouver
Jiang X, Bae S, Yoon DY, Park SJ, Oh J, Cho JY, et al. Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s409368
BibTeX
@article{Jiang2023,
author = {Jiang, Xu and Bae, Sungyeun and Yoon, Deok Yong and Park, Shin Jung and Oh, Jaeseong and Cho, Joo-Youn and Yu, Kyung-Sang},
title = {Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s409368}
}
EUVIMED